Knight Therapeutics Auf den Markt gebrachte Aktien
Was ist das Auf den Markt gebrachte Aktien von Knight Therapeutics?
Auf den Markt gebrachte Aktien von Knight Therapeutics, Inc. ist 78.556M 68.93%
Was ist die Definition von Auf den Markt gebrachte Aktien?
Der Aktien-Float- Anteil ist der Anteil der Aktien einer Gesellschaft, der sich in der Hand öffentlicher Investoren befindet, im Gegensatz zu den gesperrten Stücken
Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded
The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.
Auf den Markt gebrachte Aktien von Unternehmen in Health Care Sektor auf TSX im Vergleich zu Knight Therapeutics
Was macht Knight Therapeutics?
Knight Therapeutics Inc., a specialty pharmaceutical company, develops, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices in Canada and internationally. It offers Bijuva for the treatment of moderate to severe vasomotor symptoms associated with menopause in women with intact uterus; IMVEXXY to treat postmenopausal moderate to severe dyspareunia; IBSRELA for the treatment of irritable bowel syndrome with constipation in adults; TRELSTAR to treat advanced prostate cancer and for pain associated with endometriosis; ILUVIEN for the treatment of vision loss due to diabetic macular oedema; and NERLYNX to treat early-stage breast cancer. The company also provides Burinex, for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome; PROBUPHINE, to treat opioid addiction; and MOVANTIK for the treatment of opioid-induced constipation. In addition, it offers Vidaza to treat myelodysplastic syndrome; Abraxane for metastatic pancreatic adenocarcinoma; Halaven to treat advanced or metastatic breast cancer; Lenvima for differentiated thyroid cancer, advanced renal cell cancer, and unresectable hepatocellular carcinoma; Ladevina to treat multiple myeloma; Zyvalix for metastatic prostate cancer; Karfib to treat relapsed or refractory multiple myeloma; Leprid for advanced prostate cancer; AmBisome and Cresemba to treat fungal infection; and Impavido for leishmaniasis. Further, the company provides Ursofalk to treat biliary cirrhosis; Salofalk for ulcerative colitis; Fibridoner to treat idiopathic pulmonary fibrosis; Toliscrin for severe acute or resistant chronic infections; and Tobradosa Haler for chronic lung infections. Additionally, it finances other life science companies; and invests in life sciences venture capital funds. The company was incorporated in 2013 and is headquartered in Montreal, Canada.
Unternehmen mit auf den markt gebrachte aktien ähnlich Knight Therapeutics
- GNC hat Auf den Markt gebrachte Aktien von 78.412M 93.30%
- iomart Plc hat Auf den Markt gebrachte Aktien von 78.433M 71.40%
- Brickworks hat Auf den Markt gebrachte Aktien von 78.445M 51.53%
- Hemisphere hat Auf den Markt gebrachte Aktien von 78.474M 76.63%
- Batero Gold hat Auf den Markt gebrachte Aktien von 78.501M 68.15%
- Mainstream hat Auf den Markt gebrachte Aktien von 78.505M 56.85%
- Knight Therapeutics hat Auf den Markt gebrachte Aktien von 78.556M 68.93%
- Argentina Lithium & hat Auf den Markt gebrachte Aktien von 78.559M 61.11%
- Mosaic Brands hat Auf den Markt gebrachte Aktien von 78.567M 81.28%
- ProPhotonix hat Auf den Markt gebrachte Aktien von 78.585M 84.23%
- Confidence Intelligence hat Auf den Markt gebrachte Aktien von 78.590M 31.44%
- Angel Seafood hat Auf den Markt gebrachte Aktien von 78.621M 48.66%
- Mallinckrodt plc hat Auf den Markt gebrachte Aktien von 78.630M 92.81%